Personalised prospective comparison of ARni with ArB in patients with natriuretic peptide eLEvation (PARABLE)

Trial Profile

Personalised prospective comparison of ARni with ArB in patients with natriuretic peptide eLEvation (PARABLE)

Recruiting
Phase of Trial: Phase II

Latest Information Update: 26 Dec 2016

At a glance

  • Drugs Sacubitril/valsartan (Primary) ; Valsartan
  • Indications Cardiovascular disorders; Heart failure
  • Focus Therapeutic Use
  • Acronyms PARABLE
  • Most Recent Events

    • 26 Jun 2016 Patients with BNP between 35 and 280pg/ml or NT-proBNP values between greater than 125 pg/ml and 1,000 pg/ml are now enrolled in the study. Initially these values are greater than 50pg/ml for BNP or 250 pg/ml (NT-proBNP) at Visit 1.
    • 02 Dec 2015 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top